News & Views

Japanese Pharmaceutical Market: Sector Insights

Oct 20 2017 Read 594 Times

One of the latest market intelligence forecasts for the Japanese Pharmaceutical market from life science commercial intelligence firm Evaluate highlights both negative and positive components affecting future performance, predicting a growth rate of 3.3% (CAGR) between 2017 -2022, significantly lower than Worldwide outlook (6.5% CAGR).

According to the industry analyst the enforcement of a much more stringent pricing revision policy in Japan, both for new products as well as off-patent brands, is behind the decline of the products currently on the market which are forecast to drop about 2% annually in sales through 2022.

The prices of Gilead’s hepatitis C virus (HCV) blockbusters Sovaldi and Harvoni have been subject to significant price scrutiny and most recently the Japanese government has forced a price reduction of 50% on Opdivo, BMS’ novel PD-1/PD-L1 agent.

However, the sales decline of marketed products is counterbalanced by the optimism surrounding new therapies coming to market expected to account for 34% of sales in 2022, among the top ranking are Dupixent (Sanofi), Ibrance (Pfizer), Entresto (Novartis), Aducanumab (Biogen), and Emicizumab (Chugai).

For more information on consensus drug forecasts for the Japanese Pharma and Biotech sector visit

Read comments0

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Digital Edition

International Labmate March 2018

March 2018

In This Edition Articles Chromatography - Visiting the 15th International Symposium - New Application Book Offers Expertise in GPC Analysis - Same Separation, Speedier Solution Mass S...

View all digital editions


China Lab 2018

Mar 27 2018 Guangzhou, China


Mar 28 2018 Lyon, France


Apr 02 2018 Suntec City, Singapore

Lab Indonesia 2018

Apr 04 2018 Jakarta, Indonesia


Apr 09 2018 Marrakech, Morroco

View all events